{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:15:32Z","timestamp":1784978132556,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T00:00:00Z","timestamp":1441756800000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA049605"],"award-info":[{"award-number":["P01 CA049605"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stanford University Cancer Institute","award":["1P030 CA124435-01"],"award-info":[{"award-number":["1P030 CA124435-01"]}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bbmt.2014.04.018","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T01:35:50Z","timestamp":1398303350000},"page":"1307-1313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantation Relapse and Survival"],"prefix":"10.1016","volume":"20","author":[{"given":"Aaron C.","family":"Logan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Vashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek","family":"Faham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Carlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Bu\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Moorhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Waqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Zehnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Miklos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2014.04.018_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.seminoncol.2011.11.009","article-title":"Acute lymphoblastic leukemia: monitoring minimal residual disease as a therapeutic principle","volume":"39","author":"Bruggemann","year":"2012","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bbmt.2014.04.018_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1365-2141.2003.04135.x","article-title":"Residual leukaemia after bone marrow transplant in children with acute lymphoblastic leukaemia after first haematological relapse or with poor initial presenting features","volume":"120","author":"Bunin","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.04.018_bib3","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study","volume":"115","author":"Conter","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.04.018_bib4","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/sj.leu.2402552","article-title":"Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL","volume":"16","author":"Bader","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2014.04.018_bib5","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1182\/blood.V92.11.4072","article-title":"Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia","volume":"92","author":"Knechtli","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.04.018_bib6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1365-2141.1998.00873.x","article-title":"Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia","volume":"102","author":"Knechtli","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.04.018_bib7","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","article-title":"Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood","volume":"352","author":"van Dongen","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2014.04.018_bib8","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","article-title":"Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia","volume":"107","author":"Bruggemann","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.04.018_bib9","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1182\/blood-2011-09-377713","article-title":"Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies","volume":"120","author":"Gokbuget","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.04.018_bib10","unstructured":"EuroMRD. EuroMRD: a division of European Scientific Foundation for Laboratory HematoOncology (ESHLO). Available at: http:\/\/www.euromrd.org. Accessed November 13,\u00a02013."},{"key":"10.1016\/j.bbmt.2014.04.018_bib11","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/leu.2012.121","article-title":"EuroFlow: resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2014.04.018_bib12","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1182\/blood-2012-06-379040","article-title":"Has MRD monitoring superseded other prognostic factors in adult ALL?","volume":"120","author":"Bruggemann","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.04.018_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/mpo.10154","article-title":"PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification","volume":"41","author":"Scrideli","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.bbmt.2014.04.018_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2141.2008.07429.x","article-title":"Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches","volume":"144","author":"Ryan","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.04.018_bib15","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/sj.leu.2403444","article-title":"Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig\/TcR gene rearrangements and multicolor flow cytometric immunophenotyping","volume":"18","author":"Malec","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2014.04.018_bib16","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.leu.2403348","article-title":"Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"18","author":"Neale","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2014.04.018_bib17","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/sj.leu.2402636","article-title":"Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL","volume":"16","author":"van der Velden","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2014.04.018_bib18","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2012-07-444042","article-title":"Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia","volume":"120","author":"Faham","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.04.018_bib19","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/pbc.22709","article-title":"Detection of clonal immunoglobulin and T-cell receptor gene rearrangements in childhood acute lymphoblastic leukemia using a low-cost PCR strategy","volume":"55","author":"Assumpcao","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2014.04.018_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00005-008-0045-y","article-title":"Implementation of the standard strategy for identification of Ig\/TCR targets for minimal residual disease diagnostics in B-cell precursor ALL pediatric patients: Polish experience","volume":"56","author":"Dawidowska","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz.)"},{"key":"10.1016\/j.bbmt.2014.04.018_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ajh.20461","article-title":"Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients","volume":"80","author":"Toubai","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2014.04.018_bib22","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2014.04.018_bib23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/leu.2008.390","article-title":"Chromosome 14 copy number-dependent IGH gene rearrangement patterns in high hyperdiploid childhood B-cell precursor ALL: implications for leukemia biology and minimal residual disease analysis","volume":"23","author":"Csinady","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2014.04.018_bib24","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.leu.2403505","article-title":"TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapse","volume":"18","author":"van der Velden","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2014.04.018_bib25","doi-asserted-by":"crossref","first-page":"134ra63","DOI":"10.1126\/scitranslmed.3003656","article-title":"High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia","volume":"4","author":"Wu","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bbmt.2014.04.018_bib26","doi-asserted-by":"crossref","first-page":"21194","DOI":"10.1073\/pnas.1118357109","article-title":"High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment","volume":"108","author":"Logan","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2014.04.018_bib27","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/leu.2013.52","article-title":"Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia","volume":"27","author":"Logan","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2014.04.018_bib28","doi-asserted-by":"crossref","first-page":"12ra23","DOI":"10.1126\/scitranslmed.3000540","article-title":"Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing","volume":"1","author":"Boyd","year":"2009","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bbmt.2014.04.018_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bjh.12439","article-title":"Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma","volume":"163","author":"Armand","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.04.018_bib30","doi-asserted-by":"crossref","first-page":"13081","DOI":"10.1073\/pnas.0801523105","article-title":"Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing","volume":"105","author":"Campbell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2014.04.018_bib31","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.bmt.1704067","article-title":"Lack of clinical utility of minimal residual disease detection in allogeneic stem cell recipients with childhood acute lymphoblastic leukemia: multi-institutional collaborative study in Japan","volume":"31","author":"Imashuku","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.04.018_bib32","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.20090004","article-title":"Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function","volume":"206","author":"Trageser","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2014.04.018_bib33","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1182\/blood-2012-05-429811","article-title":"Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia","volume":"120","author":"Gawad","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.04.018_bib34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2353\/jmoldx.2009.080047","article-title":"Determining the repertoire of IGH gene rearrangements to develop molecular markers for minimal residual disease in B-lineage acute lymphoblastic leukemia","volume":"11","author":"Brisco","year":"2009","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.bbmt.2014.04.018_bib35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1046\/j.1365-2141.2003.04495.x","article-title":"Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia","volume":"122","author":"Uzunel","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.04.018_bib36","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1182\/blood-2012-07-441030","article-title":"Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL","volume":"120","author":"Topp","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.04.018_bib37","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1182\/blood-2012-01-400515","article-title":"Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19\/CD3-bispecific BiTE antibody blinatumomab","volume":"119","author":"Klinger","year":"2012","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114002572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114002572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:49:42Z","timestamp":1761058182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879114002572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1083879114002572"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.04.018","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantation Relapse and Survival","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.07.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}